MoneyWorks4Me

Twilight Litaka Pharma board to consider dividend

19 Aug 2011 Evaluate

Twilight Litaka Pharma has informed that a meeting of the board of directors of the company will be held on August 27, 2011, to consider and adopt audited financial results for the year ended on March 31, 2011 and the recommendation of dividend, if any, on the equity shares of the company.

The above information is part of the company's filing submitted to the BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..